Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Savès

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|December 5, 2018
Evidence-based medicine: basic principlesGeneviève Chêne, Linda Wittkop, Marianne Savès
Cancer Epidemiology|April 25, 2019
Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010Marie Poiseuil, Gaëlle Coureau, Catherine Payet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2002
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapyMarianne Savès, François Raffi, Jacqueline Capeau, et al.
AIDS (London, England)|July 20, 2002
Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?Corinne Rancinan, Didier Neau, Marianne Savès, et al.
Sante (Montrouge, France)|December 2, 2010
[Evaluation of the lifetime of nail markings during polio vaccinations in Chad]Huong Quoc Cuong, Martin Schlumberger, Salomon Garba Tchang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2003
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general populationMarianne Savès, Geneviève Chêne, Pierre Ducimetière, et al.
Antiviral Therapy|June 9, 2006
Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapyJean-Marie Bard, Régis Lassalle, Jacqueline Capeau, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|December 5, 2018
Evidence-based medicine: basic principlesGeneviève Chêne, Linda Wittkop, Marianne Savès
Cancer Epidemiology|April 25, 2019
Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010Marie Poiseuil, Gaëlle Coureau, Catherine Payet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2002
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapyMarianne Savès, François Raffi, Jacqueline Capeau, et al.
AIDS (London, England)|July 20, 2002
Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?Corinne Rancinan, Didier Neau, Marianne Savès, et al.
Sante (Montrouge, France)|December 2, 2010
[Evaluation of the lifetime of nail markings during polio vaccinations in Chad]Huong Quoc Cuong, Martin Schlumberger, Salomon Garba Tchang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2003
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general populationMarianne Savès, Geneviève Chêne, Pierre Ducimetière, et al.
Antiviral Therapy|June 9, 2006
Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapyJean-Marie Bard, Régis Lassalle, Jacqueline Capeau, et al.
Pageof 1